Evidence map›Paper›PMID 41647267›Full record

ArticleImaging neuroscience (Cambridge, Mass.)

Extraction of robust functional connectivity patterns across psychiatric disorders using principal component analysis-based feature selection.

Ayumu Yamashita, Takashi Itahashi, Yuki Sakai, Masahiro Takamura, Hiroki Togo, Yujiro Yoshihara, Tomohisa Okada, Hirotaka Yamagata, Kenichiro Harada, Haruto Takagishi and 17 more

Abstract read
In one paragraph

Article in Imaging neuroscience (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Ayumu YamashitaAdvanced Telecommunications Research Institute International (ATR), Brain Information Communication Research Laboratory Group, Kyoto, Japan.ORCID https://orcid.org/0000-0003-3825-2919
Takashi ItahashiMedical Institute of Developmental Disabilities Research, Showa Medical University, Tokyo, Japan.
Yuki SakaiAdvanced Telecommunications Research Institute International (ATR), Brain Information Communication Research Laboratory Group, Kyoto, Japan.
Masahiro TakamuraDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.
Hiroki TogoDepartment of Integrated Neuroanatomy and Neuroimaging, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yujiro YoshiharaDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Tomohisa OkadaHuman Brain Research Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hirotaka YamagataDivision of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Kenichiro HaradaDivision of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Haruto TakagishiBrain Science Institute, Tamagawa University, Tokyo, Japan.
Koichi HosomiDepartment of Neurosurgery, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
Naohiro OkadaInternational Research Center for Neurointelligence, Institutes for Advanced Study, The University of Tokyo, Tokyo, Japan.
Osamu AbeDepartment of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Go OkadaDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.
Yasumasa OkamotoDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.
Ryuichiro HashimotoAdvanced Telecommunications Research Institute International (ATR), Brain Information Communication Research Laboratory Group, Kyoto, Japan.
Takashi HanakawaDepartment of Integrated Neuroanatomy and Neuroimaging, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Toshiya MuraiDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Koji MatsuoDepartment of Psychiatry, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
Hidehiko TakahashiDepartment of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Kiyoto KasaiInternational Research Center for Neurointelligence, Institutes for Advanced Study, The University of Tokyo, Tokyo, Japan.
Takuya HayashiCenter for Biosystems Dynamics Research (BDR), RIKEN, Hyogo, Japan.
Shinsuke KoikeInternational Research Center for Neurointelligence, Institutes for Advanced Study, The University of Tokyo, Tokyo, Japan.
Saori C TanakaAdvanced Telecommunications Research Institute International (ATR), Brain Information Communication Research Laboratory Group, Kyoto, Japan.
Mitsuo KawatoAdvanced Telecommunications Research Institute International (ATR), Brain Information Communication Research Laboratory Group, Kyoto, Japan.
Hiroshi ImamizuAdvanced Telecommunications Research Institute International (ATR), Brain Information Communication Research Laboratory Group, Kyoto, Japan.
Okito YamashitaAdvanced Telecommunications Research Institute International (ATR), Brain Information Communication Research Laboratory Group, Kyoto, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research on biomarkers for predicting psychiatric disorders from resting-state functional connectivity (FC) is advancing. While the focus has primarily been on the discriminative performance of biomarkers by machine learning, identification of abnormal FCs in psychiatric disorders has often been treated as a secondary goal. However, it is crucial to investigate the effect size and robustness of the selected FCs because they can be used as potential targets of neurofeedback training or transcranial magnetic stimulation therapy. Here, we incorporated approximately 5,000 runs of resting-state functional magnetic resonance imaging from six datasets, including individuals with three different psychiatric disorders (major depressive disorder [MDD], schizophrenia [SCZ], and autism spectrum disorder [ASD]). We demonstrated that a PCA-based feature selection method can robustly extract FCs related to psychiatric disorders compared with other conventional supervised feature selection methods. We found that our proposed method robustly extracted FCs with larger effect sizes from the validation dataset compared with different types of feature selection methods based on supervised learning for MDD (Cohen's d = 0.40 vs. 0.25), SCZ (0.37 vs. 0.28), and ASD (0.17 vs. 0.16). We found 78, 69, and 81 essential FCs for MDD, SCZ, and ASD, respectively, and these FCs were mainly thalamic and motor network FCs. The current study showed that the PCA-based feature selection method robustly identified abnormal FCs in psychiatric disorders consistently across datasets. The discovery of such robust FCs will contribute to understanding neural mechanisms as abnormal brain signatures in psychiatric disorders.

Indexed as

feature selectionfMRImachine learningPCApsychiatric disorderresting-state functional connectivity

Identifiers

PMID41647267
PMCPMC12869322

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.